Abstract
We have studied the in vitro TSH secretion and the adenylate cyclase (AC) activity of a human pituitary adenoma surgically removed from a hyperthyroid patient showing high serum TSH levels. The tumor appeared almost homogeneously constituted by cells positive for an anti-TSH-beta antiserum and showing the ultrastructural characteristics of the adenomatous thyrotrophs. Adenoma fragments released in vitro a large amount of TSH (148.4 μU/mg prot/30 min), alpha-subunit(35.5 ng/mg prot/30 min) and TSH-beta (10.1 ng/mg prot/30 min). The effects of somatostatin (GHRIH) and dopamine (DA) on the hormone release have been tested in vitro. Both agents markedly inhibited the release of intact TSH and TSH-beta whereas the release of alpha-subunit was less affected. The two agents were effective at concentrations higher than 10−8M. The ability of GHRIH and DA in modulating the AC activity was investigated in membrane fraction preparations. GHRIH inhibited AC at concentrations higher than 10 −7M. The maximal inhibition was 32% at 10−5 M. Conversely, DA slightly stimulated AC activity. This effects was not mimicked by the dopaminergic ergot CH 29–717, which was completely ineffective on the enzyme. These results suggest that: 1) in this TSH-secreting pituitary adenoma a normal secretory response to the inhibiting agents (GHRIH and DA) is present; 2) different mechanisms of transduction of the GHRIH and DA signals (cAMP dependent and cAMP independent) could be operating in this tumor.
Similar content being viewed by others
References
Smallridge R.C., Wortofsky L., Dimond R.C. Inappropriate secretion of thyrotropin: discordance between the suppressive effects of corticosteroids and thyroid hormone. J. Clin. Endocrinol. Metab. 48: 700, 1979.
Faglia G., Beck Peccoz P., Piscitelli G., Spada A. Clinical aspects and treatment of TSH-secreting pituitary adenomas and non neoplastic inappropriate secretion of TSH. In: Lamberts S.W.J., Tilders F.J.H., Van der Veen E.A., Assies J. (Eds.), Trends in diagnosis and treatment of pituitary adenomas. Free-University Press, Amsterdam, 1984, p. 273.
Tolis G., Bird C., Bertrand G., Mackenzie J.M., Ezrin C. Pituitary hyperthyroidism. Am. J. Med. 64: 177, 1978.
Kourides I.A., Ridgway E.C., Weintraub B.D., Bigos S.T., Gershengorn M.C., Maloof E. Thyrotropin-induced hyperthyroidism: use of alpha and beta subunit levels to identify patients with pituitary tumors. J. Clin. Endocrinol. Metab. 45: 534, 1977.
Smallridge R.C., Smith C.E. Hyperthyroidism due to thyrotropin secreting pituitary tumors. Diagnostic and therapeutic considerations. Arch. Intern. Med. 143: 503, 1983.
Benoit R., Pearson-Murphy B.E., Robert F., Marcovitz S., Hardy J., Tsoukas G., Gardiner B.J. Hyperthyroidism due to a pituitary TSH secreting tumor with amenorrhea-galactorrhea. Clin. Endocrinol. (Oxf.) 12: 11, 1980.
Siler T.M., Yen S.S.C., Vale W., Guillemin R. Inhibition by somatostatin on the release of TSH induced in man by thyrotropin releasing factor. J. Clin. Endocrinol. Metab. 38: 742, 1974.
Healy D.L., Burger H.G. Increased prolactin and thyrotropin secretion following oral metoclopramide: dose response relationship. Clin. Endocrinol. (Oxf.) 7: 195, 1977.
Horn K., Erhardt F., Fahlbush R., Pickardt C.R., Von Werder K., Scriba P.C. Recurrent goiter, galactorrhea and amenorrhea due to thyrotropin and prolactin producing pituitary tumor. J. Clin. Endocrinol. Metab. 43: 137, 1976.
Werner S. Human pituitary adenomas with hypersecretion of TSH and prolactin: evidence that receptor sites for dopamine may be present on TSH-producing while present on prolactin-producing cells. Horm. Metab. Res. 11: 452, 1979.
Filetti S., Rapoport B., Aron D.C., Greenspan F.C., Wilson C.B., Fraser W. TSH and TSH-subunit production by human thyrotropic tumour cells in monolayer culture. Acta Endocrinol. (Kbh.) 99: 224, 1982.
Lamberts S.W.J., Oosterom R., Verleun T., Krenning E.P., Assies H. Regulation of hormone release by cultured cells from a thyrotropin-growth hormone secreting pituitary tumor. Direct inhibitory effects of 3,5,3′-triiodothyronine and dexamethasone on thyrotropin secretion. J. Endocrinol. Invest. 7: 313, 1984.
Giannattasio G., De Ferrari M.E., Spada A. Dopamine-inhibited adenylate cyclase in female rat adenohypophysis. Life Sci. 28: 1605, 1981.
Swennen L., Denef C. Physiological concentrations of dopamine decrease adenosine 3′–5′ monophosphate levels in cultured rat anterior pituitary cells and enriched populations of lactotrophs. Evidence for causal relationship to inhibition of prolactin release. Endocrinology 111: 393, 1982.
Spada A., Vallar L., Giannattasio G. Presence of an adenylate cyclase dually regulated by somatostatin and human pancreatic GH releasing factor in GH-secreting cells. Endocrinology, 115: 1203, 1984.
Spada A., Nicosia S., Cortelazzi L., Pezzo G., Bassetti M., Sartorio A., Giannattasio G. In vitro studies on prolactin release and adenylate cyclase activity in human prolactin-secreting pituitary adenomas. Different sensitivity of macro- and microadenomas to dopamine and vasoactive intestinal polypeptide. J. Clin. Endocrinol. Metab. 56: 1, 1983.
Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265, 1951.
Salomon Y., Londos C., Rodbell M.A. A highly sensitive adenylate cyclase assay. Annal. Biochem. 58: 541, 1974.
Faglia G., Beck Peccoz P., Ferrari C., Travaglini P., Ambrosi B. Plasma thyrotropin response to thyrotropin-releasing hormone in patients with pituitary and hypothalamic disorders. J. Clin. Endocrinol. Metab. 37: 595, 1973.
Faglia G., Beck Peccoz P., Ballabio M., Nava C. Excess of beta-subunit of thyrotropin (TSH) in patients with idiopathic central hypothyroidism due to the secretion of TSH with reduced biological activity. J. Clin. Endocrinol. Metab. 56: 908, 1983.
Mosca L., Solcia E., Capella C., Buffa R. Pituitary adenomas: surgical versus post mortem findings today. In: Faglia G., Giovannelli M.A., MacLeod R.M. (Eds.), Pituitary Microadenomas. Academic Press, London, 1980, p. 137.
Mashiter K., Van Noorden S., Fahlbush R., Fill H., Skrabal K. Hyperthyroidism due to a TSH secreting pituitary adenoma: case report, treatment and evidence for adenoma TSH by morphological and cell culture studies. Clin. Endocrinol. (Oxf.) 18: 473, 1983.
Blackman M.R., Gershengorn M.C., Weintraub B.D. Excess production of free alpha subunit by mouse pituitary thyrotropic tumor cells in vitro. Endocrinology 102: 499, 1978.
Vale W., Rivier C., Brazeau P., Guillemin R. Effects of somatostatin on the secretion of thyrotropin and prolactin. Endocrinology 95: 968, 1974.
Foord S.M., Peters J., Scanion F., Rees Smith B., Hall R. Dopaminergic control of TSH secretion in isolated rat pituitary cells. FEBS Lett. 121: 257, 1980.
Foord S.M., Peters J.R., Dieguez C., Scanlon M.F., Hall R. Dopamine receptors on intact anterior pituitary cells in culture: functional association with the inhibition of prolactin and thyrotropin. Endocrinology 112: 1567, 1983.
Labrie F., Pelletier G., Borgeat P., Drouin J., Ferland L., Belanger A. Mode of action of hypothalamic regulatory hormones in the adenohypophysis. In: Martini L. and Ganong W.F. (Eds.), Frontiers in Neuroendocrinology. Raven Press, New York, 1976, vol.4, p. 63.
Kebabian J.W., Calne D.B. Multiple receptors for dopamine. Nature 227: 93, 1979.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Spada, A., Bassetti, M., Martino, E. et al. In vitro studies on TSH secretion and adenylate cyclase activity in a human TSH-secreting pituitary adenoma. Effects of somatostatin and dopamine. J Endocrinol Invest 8, 193–198 (1985). https://doi.org/10.1007/BF03348476
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03348476